EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

EIF3E::RSPO2 Fusion in Metastatic Pancreatic Ductal Adenocarcinoma: A Clinical Case Report Suggesting a Putative KRAS-Independent Molecular Profile

José María Sayagués iD, Mar Abad, Diego Bueno-Sacristán iD, Magdalena Sancho, María Belen Rivas, María Teresa Alonso-Márquez, Ana María Moreno, Juan Carlos Montero iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27135679 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von José María Sayagués und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, 37007 Salamanca, Spain. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Proto-Oncogene Proteins p21(ras), Thrombospondins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is molecularly characterized by near-universal KRAS mutations and recurrent alterations in TP53, CDKN2A, and SMAD4. Gene fusions are exceptionally rare and have not been established as canonical drivers of PDAC. We report a case of metastatic PDAC harboring an EIF3E::RSPO2 gene fusion in the absence of detectable KRAS or other common driver mutations. A 48-year-old female was diagnosed with stage IV PDAC via endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA). Comprehensive molecular profiling using the Oncomine Precision Assay GX5 revealed no pathogenic single-nucleotide variants, indels, or copy number variations. However, an EIF3E::RSPO2 fusion, predicted to be a gain-of-function alteration, was identified as the sole genomic alteration. Immunohistochemistry showed retained mismatch repair protein expression and preserved SMAD4. Although RSPO2 fusions have been described in preclinical colorectal cancer models and are well-established activators of the Wnt signaling pathway in this setting, their clinical occurrence in PDAC remains poorly documented. This finding indicates a KRAS wild-type tumor with a potential KRAS-independent oncogenic mechanism that may involve aberrant Wnt/β-catenin signaling and raises the possibility of a rare, biologically distinct PDAC subset. Comprehensive genomic profiling in advanced PDAC may uncover actionable non-canonical drivers with therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsProto-Oncogene Proteins p21(ras)ThrombospondinsEukaryotic Initiation FactorsOncogene Proteins, FusionHumansFemaleMiddle AgedR-Spondins

Stichwörter der Autor:innen

EIF3E::RSPO2PDACWnt/β-catenin pathwaygene fusionpersonalized medicinetumor genomics

Substanzen

Proto-Oncogene Proteins p21(ras)ThrombospondinsR-SpondinsEukaryotic Initiation FactorsKRAS protein, humanOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Pathology, Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, 37007 Salamanca, Spain.
  • Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Department of Pharmacy, Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, 37007 Salamanca, Spain.

ORCID-Profile: José María Sayagués, Diego Bueno-Sacristán, Juan Carlos Montero

Förderung

  • Instituto de Salud Carlos III
  • European Union

Zitieren

APA

Sayagués, J. M., Abad, M., Bueno-Sacristán, D., Sancho, M., Rivas, M. B., Alonso-Márquez, M. T., Moreno, A. M., & Montero, J. C. (2026). EIF3E::RSPO2 Fusion in Metastatic Pancreatic Ductal Adenocarcinoma: A Clinical Case Report Suggesting a Putative KRAS-Independent Molecular Profile. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27135679

Vancouver

Sayagués JM, Abad M, Bueno-Sacristán D, Sancho M, Rivas MB, Alonso-Márquez MT, et al. EIF3E::RSPO2 Fusion in Metastatic Pancreatic Ductal Adenocarcinoma: A Clinical Case Report Suggesting a Putative KRAS-Independent Molecular Profile. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27135679

BibTeX
@article{Sayagus2026,
  author = {Sayagués, José María and Abad, Mar and Bueno-Sacristán, Diego and Sancho, Magdalena and Rivas, María Belen and Alonso-Márquez, María Teresa and Moreno, Ana María and Montero, Juan Carlos},
  title = {EIF3E::RSPO2 Fusion in Metastatic Pancreatic Ductal Adenocarcinoma: A Clinical Case Report Suggesting a Putative KRAS-Independent Molecular Profile},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27135679}
}
Kostenlos starten →